Sotalol, a Pure Beta‐Adrenergic Blocking Agent for Treatment of Essential Hypertension and Other Cardiovascular Diseases
- 9 August 1979
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 19 (8-9) , 497-504
- https://doi.org/10.1002/j.1552-4604.1979.tb02514.x
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- The Combination of Sotalol and Hydrochlorothiazide in the Treatment of HypertensionThe Journal of Clinical Pharmacology, 1979
- Crossover Comparison of Sotalol Plus Methyldopa in HypertensionThe Journal of Clinical Pharmacology, 1979
- Thrice‐Daily Blood Pressure Readings on Sotalol in the Treatment of Hypertension: Once‐ Versus Twice‐Daily RegimenThe Journal of Clinical Pharmacology, 1979
- Pharmacologic Considerations in Determining Efficacy of Once‐Daily Sotalol Administration to Hypertensive PatientsThe Journal of Clinical Pharmacology, 1979
- Studies on the Pharmacokinetics and Pharmacodynamics of the Beta‐Adrenergic Blocking Agent Sotalol in Normal ManThe Journal of Clinical Pharmacology, 1979
- Blunting of Exercise‐Induced Tachycardia and Renin Release 24 Hours After a Single Dose of SotalolThe Journal of Clinical Pharmacology, 1979
- Effects of the Beta‐Adrenoceptor Blocking Agent Sotalol on CNS: Sleep, EEG, and Psychophysiological ParametersThe Journal of Clinical Pharmacology, 1979
- Long‐Term Sotalol Therapy in Patients with ArrhythmiasThe Journal of Clinical Pharmacology, 1979
- Pharmacokinetic Properties of the ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- Beta adrenergic blockade and juvenile diabetes: Acute studies and long-term therapeutic trial: Evidence for the role of catecholamines in mediating diabetic decompensation following emotional arousalThe Journal of Pediatrics, 1969